An In-situ Detection for MicroRNA

Recruiting

• Conditions: Breast Cancer

• Registration Number: NCT06529614
• Lead Sponsor: Tongji Hospital

Brief Summary

We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-07
• Study Start: 2024-07-20
• Study First Submitted: 2024-07-26
• Study First Submitted QC: 2024-07-26
• Last Update Submitted: 2024-07-26
• Study First Posted: 2024-07-31
• Last Update Posted: 2024-07-31
• Primary Completion: 2025-04
• Study Completion: 2025-04

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Healthy without serious diseases

Exclusion Criteria

• situations that may affect the results

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sensitivity and specificity of test	8 months

Trial Locations

Locations (1)

Tongji Hospital; 🇨🇳 Wuhan, Hubei, China